Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.
about
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALSTransplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injuryDietary supplementations as neuroprotective therapies: focus on NT-020 diet benefits in a rat model of strokeNovel molecular biomarkers at the blood-brain barrier in ALSMicroglia centered pathogenesis in ALS: insights in cell interconnectivityBlood-CNS Barrier Impairment in ALS patients versus an animal modelChronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALSThe blood-spinal cord barrier: morphology and clinical implicationsPhysical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort studyReduction of circulating endothelial cells in peripheral blood of ALS patientsPresymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.Blood-brain barrier impairment in an animal model of MPS III BALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.The blood-brain barrier in health and disease.Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model.Blood-brain barrier alterations provide evidence of subacute diaschisis in an ischemic stroke rat modelInhibiting drug efflux transporters improves efficacy of ALS therapeuticsGene therapy for the nervous system: challenges and new strategies.Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity.The role of environmental exposures in neurodegeneration and neurodegenerative diseases.Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone.Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms.Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats.Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.Neurovascular unit in chronic pain.Stem cells in amyotrophic lateral sclerosis: state of the art.Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis.Neurological diseases in relation to the blood-brain barrier.CSF markers in amyotrophic lateral sclerosis.Immunological aspects in amyotrophic lateral sclerosis.Targeted delivery of protein and gene medicines through the blood-brain barrier.Cord blood as a potential therapeutic for amyotrophic lateral sclerosis.Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier RepairPotential new complication in drug therapy development for amyotrophic lateral sclerosis.Brain metabolism in health, aging, and neurodegeneration.Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.
P2860
Q21144409-5830B2B5-0BB1-46F8-88F9-E93C7181C388Q26825854-D3D1C17A-2AD7-40C8-8DF8-2FD00742078FQ26991784-0A811DFD-D830-4341-9574-59FC74ED382AQ27004431-1BBBFA17-EE5B-4A5D-B7D1-FC261CED888EQ27009559-CFA5A48E-BE7D-45DF-91C5-7506FACBFF65Q27026792-679D0A24-74A4-4062-81C9-4A28A5A842B8Q27303112-A90A69AD-04EF-4731-8ED6-A5B208B3F875Q28240807-03554AF0-2E8A-40EB-8127-A299086E7A45Q28391291-73D4D942-95BC-4BCA-BA7D-F9588FE7A57BQ28752226-36D9C672-F1FE-4567-A35D-627BE2ED4EF6Q30746065-DF87041C-9313-4472-A5EA-8A9FD4A868F7Q33581148-8A17F954-C22E-4893-B2D9-74F10E62F7ACQ33847821-6BDC9700-9D72-4B54-9ABE-C6325FFC1EDAQ33954016-E41E4C2F-0461-40AB-BA72-BAD2E1F19D9DQ34320420-B5AC31A5-12A5-4B9A-971C-94361CF225E2Q34417341-BCA98FFF-C0F1-4725-A6D4-882D436E6923Q34722888-ABDA201E-34D6-4EBB-9E72-BA2685B9BE50Q34824777-451E70BB-D8D9-4602-B872-B70959ED5C1CQ35340196-B513E8E9-A16E-4668-AEE7-B34A66ADA711Q35534472-DD4052DD-02D1-49ED-A384-0D187C803286Q35551001-02AE85E0-CE80-462D-89C5-71BA40C1E6A6Q35609617-9D0410E7-21A7-4851-A309-B3276373E48EQ35779264-D1BB34C7-29F3-4600-9E5F-9137D917C995Q36007494-EF37E515-B3D6-46C0-805D-1422F3940BD2Q36142384-0862C575-A5B6-4B8D-BCDA-F39A0D04B3E0Q36503292-F1E17A5D-F478-4CD7-BDC8-6505EC6DDCB5Q36672336-7EBDC170-02E2-4A53-81CA-7A880886E657Q36680605-0996DE01-D7AC-42A3-B4CB-08108FAA8CF8Q36942721-25C1F561-F544-439B-8B3E-BBC3CE724F66Q37575591-A2F40C36-3FA4-43BB-B60C-96A60D4B3F81Q37960903-781C25DD-7A03-4E70-A7C5-079FF6328FAEQ37976564-20D5E80B-12C8-4D35-9BE9-46360DBDCD11Q38007362-4E4E5BF4-998E-4C19-BCEF-729F8043F2E4Q38170060-9A83C212-20AB-4B61-B4E9-AEB3D696F94AQ38351122-4C02BA1C-39FE-4CAD-A9B0-FA6EED45C2F6Q38690849-7475DDC8-F3D2-4065-B62A-BD808BA2B00DQ38730523-74BA3D99-2B50-41B0-8460-944B13B34EFBQ38881707-FD307236-1CDA-4F15-A62D-87E67133BD66Q39259780-6C82257C-0078-4DBC-9CCC-00958083AE4CQ41488070-61588F5B-40CC-4421-8666-A5B25C9BE56B
P2860
Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@ast
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@en
type
label
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@ast
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@en
prefLabel
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@ast
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@en
P2093
P1433
P1476
Ultrastructure of blood-brain ...... ier in SOD1 mice modeling ALS.
@en
P2093
Irina Kolomey
Paul R Sanberg
Samuel Saporta
Santo V Nicosia
Svitlana Garbuzova-Davis
P304
P356
10.1016/J.BRAINRES.2007.04.044
P407
P577
2007-04-24T00:00:00Z